Medovate Archives - Journal of Anaesthesia Practice

14 February 2023

Medovate announces agreement with Qualitech Healthcare

Medovate, a Cambridge based manufacturer of innovative medical technologies created from within the NHS, has concluded an agreement with Qualitech...

23 June 2022

Medovate secures HSA approval in Singapore for SAFIRA® system

Medovate and its Singapore-based distributor Bluestone Corporation Pte Ltd have announced they have secured Singapore’s Health Sciences Authority (HSA) approval for the...

17 May 2022

Medovate wins ‘Medtech Company of the Year’ at Cambridge Independent Awards

Medovate has been awarded ‘Medtech Company of the Year’ at the Cambridge Independent Science and Technology Awards for 2022. Based...

12 January 2022

Regional anaesthesia device SAFIRA® demonstrated live at Arab Health 2022

A UK technology that transforms regional anaesthesia into a single operator procedure and improves patient safety, will be demonstrated live...

27 October 2020

Vygon signs exclusive agreement with Medovate to distribute regional anaesthesia device

Vygon Group, a group specialising in single-use medical devices, and Medovate, a medical device company dedicated to the development and...

9 June 2020

Medovate partners with New York School of Regional Anesthesia

Medical device company Medovate is partnering with the New York School of Regional Anesthesia (NYSORA) to support the launch of...

16 April 2020

Medovate secures distributors in US for SAFIRA

Medical device development company Medovate has concluded agreements with three companies to act as the exclusive distributors for its Food...

BROWSE BY SECTION

About Us

Journal of Anaesthesia Practice is a leading online title in the field of anaesthesia

Journal of Anaesthesia Practice is a unique online vehicle for getting an anaesthetic product or service in front of the people who really matter. The vast majority of the readership are consultant anaesthetists.

Medovate

Medovate announces agreement with Qualitech Healthcare

Medovate secures HSA approval in Singapore for SAFIRA® system

Medovate wins ‘Medtech Company of the Year’ at Cambridge Independent Awards

Regional anaesthesia device SAFIRA® demonstrated live at Arab Health 2022

Vygon signs exclusive agreement with Medovate to distribute regional anaesthesia device

Medovate partners with New York School of Regional Anesthesia

Medovate secures distributors in US for SAFIRA

Central Medical Supplies appoints new Account Manager

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Willis-Ekbom Disease (Restless Leg Syndrome, Night-Walker’s Syndrome): Anaesthetic implications and management

SURGhub reaches record 19,000 healthcare workers across 190 countries

8-9 August 2025, AfPP Annual National Conference 2025; Warwick

Anaesthetic challenges and management of Constrictive Pericarditis

About Us

Medovate

Medovate announces agreement with Qualitech Healthcare

Medovate secures HSA approval in Singapore for SAFIRA® system

Medovate wins ‘Medtech Company of the Year’ at Cambridge Independent Awards

Regional anaesthesia device SAFIRA® demonstrated live at Arab Health 2022

Vygon signs exclusive agreement with Medovate to distribute regional anaesthesia device

Medovate partners with New York School of Regional Anesthesia

Medovate secures distributors in US for SAFIRA

and receive all of the latest news via our weekly newsletter

Central Medical Supplies appoints new Account Manager

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Willis-Ekbom Disease (Restless Leg Syndrome, Night-Walker’s Syndrome): Anaesthetic implications and management

SURGhub reaches record 19,000 healthcare workers across 190 countries

8-9 August 2025, AfPP Annual National Conference 2025; Warwick

Anaesthetic challenges and management of Constrictive Pericarditis

About Us

Subscribe

and receive all of the latest news via our weekly newsletter